A carregar...
Chronic Myeloid Leukemia- The Promise of Tyrosine Kinase Inhibitor Discontinuation
Some believe that tyrosine kinase inhibitor (TKI) therapy is as close to perfect as it gets in oncologic therapy. Patients diagnosed with chronic myeloid leukemia (CML) are treated with a daily oral therapy, through which most achieve remission. TKI therapy is not associated with classic chemotherap...
Na minha lista:
| Publicado no: | Curr Hematol Malig Rep |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2017
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6045428/ https://ncbi.nlm.nih.gov/pubmed/28944397 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s11899-017-0404-z |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|